Pancreatic Cancer
Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer. De...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2010-04, Vol.362 (17), p.1605-1617 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1617 |
---|---|
container_issue | 17 |
container_start_page | 1605 |
container_title | The New England journal of medicine |
container_volume | 362 |
creator | Hidalgo, Manuel |
description | Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer.
Deaths from pancreatic cancer rank fourth among cancer-related deaths in the United States. This article summarizes recent progress in the understanding and management of pancreatic cancer.
Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States. In 2008, the estimated incidence of pancreatic cancer in the United States was 37,700 cases, and an estimated 34,300 patients died from the disease.
1
Pancreatic cancer is more common in elderly persons than in younger persons, and less than 20% of patients present with localized, potentially curable tumors. The overall 5-year survival rate among patients with pancreatic cancer is |
doi_str_mv | 10.1056/NEJMra0901557 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733929451</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733929451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-8887d128ee54ceb532578267771e4c33b63b0f86282f0fad05109f7322435b3d3</originalsourceid><addsrcrecordid>eNp10LtLA0EQBvBFFBOjhYWt2IjV6ezOPks54ov4KLRe9vbmICGXxN2kyH_vyUXBwmlmih8fzMfYGYdrDkrfvIyfnlMAB1wps8eGXCEWUoLeZ0MAYQtpHA7YUc4z6IZLd8gGAqQwFtyQnb6FRUwU1tN4UXYnpWN20IR5ppPdHrGPu_F7-VBMXu8fy9tJEVHrdWGtNTUXlkjJSJVCoYwV2hjDSUbESmMFjdXCigaaUIPi4BqDQkhUFdY4Yld97iotPzeU176d5kjzeVjQcpO9QXTCScU7WfQypmXOiRq_StM2pK3n4L9L8H9K6Pz5LnlTtVT_6p-vO3DZg7bNfkGz9p-gLzBuXx8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733929451</pqid></control><display><type>article</type><title>Pancreatic Cancer</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Hidalgo, Manuel</creator><creatorcontrib>Hidalgo, Manuel</creatorcontrib><description>Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer.
Deaths from pancreatic cancer rank fourth among cancer-related deaths in the United States. This article summarizes recent progress in the understanding and management of pancreatic cancer.
Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States. In 2008, the estimated incidence of pancreatic cancer in the United States was 37,700 cases, and an estimated 34,300 patients died from the disease.
1
Pancreatic cancer is more common in elderly persons than in younger persons, and less than 20% of patients present with localized, potentially curable tumors. The overall 5-year survival rate among patients with pancreatic cancer is <5%.
1
,
2
The causes of pancreatic cancer remain unknown. Several environmental factors have been implicated, but evidence of a causative role exists . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMra0901557</identifier><identifier>PMID: 20427809</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Antineoplastic Agents - therapeutic use ; Combined Modality Therapy ; Deoxycytidine - analogs & derivatives ; Deoxycytidine - therapeutic use ; Humans ; Neoplasm Staging - methods ; Pancreatic Neoplasms - diagnosis ; Pancreatic Neoplasms - etiology ; Pancreatic Neoplasms - pathology ; Pancreatic Neoplasms - therapy ; Risk Factors ; Smoking - adverse effects</subject><ispartof>The New England journal of medicine, 2010-04, Vol.362 (17), p.1605-1617</ispartof><rights>Copyright © 2010 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-8887d128ee54ceb532578267771e4c33b63b0f86282f0fad05109f7322435b3d3</citedby><cites>FETCH-LOGICAL-c366t-8887d128ee54ceb532578267771e4c33b63b0f86282f0fad05109f7322435b3d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMra0901557$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMra0901557$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,780,784,2758,2759,26102,27923,27924,52381,54063,64386</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20427809$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hidalgo, Manuel</creatorcontrib><title>Pancreatic Cancer</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer.
Deaths from pancreatic cancer rank fourth among cancer-related deaths in the United States. This article summarizes recent progress in the understanding and management of pancreatic cancer.
Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States. In 2008, the estimated incidence of pancreatic cancer in the United States was 37,700 cases, and an estimated 34,300 patients died from the disease.
1
Pancreatic cancer is more common in elderly persons than in younger persons, and less than 20% of patients present with localized, potentially curable tumors. The overall 5-year survival rate among patients with pancreatic cancer is <5%.
1
,
2
The causes of pancreatic cancer remain unknown. Several environmental factors have been implicated, but evidence of a causative role exists . . .</description><subject>Antineoplastic Agents - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Deoxycytidine - analogs & derivatives</subject><subject>Deoxycytidine - therapeutic use</subject><subject>Humans</subject><subject>Neoplasm Staging - methods</subject><subject>Pancreatic Neoplasms - diagnosis</subject><subject>Pancreatic Neoplasms - etiology</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Neoplasms - therapy</subject><subject>Risk Factors</subject><subject>Smoking - adverse effects</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10LtLA0EQBvBFFBOjhYWt2IjV6ezOPks54ov4KLRe9vbmICGXxN2kyH_vyUXBwmlmih8fzMfYGYdrDkrfvIyfnlMAB1wps8eGXCEWUoLeZ0MAYQtpHA7YUc4z6IZLd8gGAqQwFtyQnb6FRUwU1tN4UXYnpWN20IR5ppPdHrGPu_F7-VBMXu8fy9tJEVHrdWGtNTUXlkjJSJVCoYwV2hjDSUbESmMFjdXCigaaUIPi4BqDQkhUFdY4Yld97iotPzeU176d5kjzeVjQcpO9QXTCScU7WfQypmXOiRq_StM2pK3n4L9L8H9K6Pz5LnlTtVT_6p-vO3DZg7bNfkGz9p-gLzBuXx8</recordid><startdate>20100429</startdate><enddate>20100429</enddate><creator>Hidalgo, Manuel</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100429</creationdate><title>Pancreatic Cancer</title><author>Hidalgo, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-8887d128ee54ceb532578267771e4c33b63b0f86282f0fad05109f7322435b3d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antineoplastic Agents - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Deoxycytidine - analogs & derivatives</topic><topic>Deoxycytidine - therapeutic use</topic><topic>Humans</topic><topic>Neoplasm Staging - methods</topic><topic>Pancreatic Neoplasms - diagnosis</topic><topic>Pancreatic Neoplasms - etiology</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Neoplasms - therapy</topic><topic>Risk Factors</topic><topic>Smoking - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hidalgo, Manuel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hidalgo, Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pancreatic Cancer</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2010-04-29</date><risdate>2010</risdate><volume>362</volume><issue>17</issue><spage>1605</spage><epage>1617</epage><pages>1605-1617</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States, yet the causes of pancreatic cancer remain unknown. This review article summarizes recent progress in the understanding and management of pancreatic cancer.
Deaths from pancreatic cancer rank fourth among cancer-related deaths in the United States. This article summarizes recent progress in the understanding and management of pancreatic cancer.
Deaths from pancreatic ductal adenocarcinoma, also known as pancreatic cancer, rank fourth among cancer-related deaths in the United States. In 2008, the estimated incidence of pancreatic cancer in the United States was 37,700 cases, and an estimated 34,300 patients died from the disease.
1
Pancreatic cancer is more common in elderly persons than in younger persons, and less than 20% of patients present with localized, potentially curable tumors. The overall 5-year survival rate among patients with pancreatic cancer is <5%.
1
,
2
The causes of pancreatic cancer remain unknown. Several environmental factors have been implicated, but evidence of a causative role exists . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>20427809</pmid><doi>10.1056/NEJMra0901557</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 2010-04, Vol.362 (17), p.1605-1617 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_proquest_miscellaneous_733929451 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
subjects | Antineoplastic Agents - therapeutic use Combined Modality Therapy Deoxycytidine - analogs & derivatives Deoxycytidine - therapeutic use Humans Neoplasm Staging - methods Pancreatic Neoplasms - diagnosis Pancreatic Neoplasms - etiology Pancreatic Neoplasms - pathology Pancreatic Neoplasms - therapy Risk Factors Smoking - adverse effects |
title | Pancreatic Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T17%3A22%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pancreatic%20Cancer&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Hidalgo,%20Manuel&rft.date=2010-04-29&rft.volume=362&rft.issue=17&rft.spage=1605&rft.epage=1617&rft.pages=1605-1617&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMra0901557&rft_dat=%3Cproquest_cross%3E733929451%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733929451&rft_id=info:pmid/20427809&rfr_iscdi=true |